ASRS
APGE

Arizona State Retirement System’s Apogee Therapeutics APGE Stock Holding History

Arizona State Retirement System’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
10,539
+29
+0.3% +$2.61K 0.01% 968
2026
Q1 		$885K Buy
10,510
+1,747
+20% +$127K 0.01% 1157
2025
Q4 		$661K Buy
8,763
+2,161
+33% +$136K ﹤0.01% 1330
2025
Q3 		$262K Buy
6,602
+114
+2% +$4.35K ﹤0.01% 1847
2025
Q2 		$282K Buy
6,488
+36
+0.6% +$1.37K ﹤0.01% 1758
2025
Q1 		$241K Sell
6,452
-65
-1% -$2.51K ﹤0.01% 1799
2024
Q4 		$295K Buy
6,517
+960
+17% +$49K ﹤0.01% 1765
2024
Q3 		$326K Sell
5,557
-436
-7% -$20.9K ﹤0.01% 1716
2024
Q2 		$236K Buy
5,993
+258
+4% +$12.5K ﹤0.01% 1819
2024
Q1 		$381K Buy
+5,735
New +$250K ﹤0.01% 1592

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Arizona State Retirement System's APGE Position: Q2 2026 in Review

Arizona State Retirement System increased its Apogee Therapeutics (APGE) stake by 0.28% in Q2 2026, buying an estimated $2.61K and bringing the position to 10,539 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #968.

Arizona State Retirement System first reported a position in APGE in Q1 2024 and has held it in 10 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Arizona State Retirement System held 10,539 shares of Apogee Therapeutics worth $1.4M as of Q2 2026.
  • Arizona State Retirement System bought 29 Apogee Therapeutics shares in Q2 2026, an estimated $2.61K.
  • Apogee Therapeutics made up 0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #968 holding.
  • Arizona State Retirement System first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.